by admin | Jun 2, 2025 | News & Opinions
By Derek Lowe – Science – Here’s some more good news on the immuno-oncology front. Hodgkin lymphoma (HL) is one of those cancer types whose prognosis is in the “A lot better than it used to be, but. . .” category. There are several varieties (with the...
by admin | May 30, 2025 | News & Opinions
By Willow Shah-Neville – LabBioTech – Parkinson’s disease is an extremely complex condition to treat. Although there are medications available that can help relieve symptoms, there are still no approved therapies that slow down the progression of the...
by admin | May 29, 2025 | News & Opinions
By Robert Sanders – UC Berkley News – In a decision released today (May 12), the U. S. Court of Appeals for the Federal Circuit in Washington, D.C., ordered the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) to reconsider its 2022...
by admin | May 28, 2025 | News & Opinions
by Kerstin Wagner, Leibniz – MedicalXpress.com – Scientists at the Leibniz Institute on Aging—Fritz Lipmann Institute (FLI) in Jena have discovered a previously unknown function of immune cells in the bone marrow. Embryonic macrophages—specialized...
by admin | May 27, 2025 | News & Opinions
By Nick Paul Taylor – Fierce Biotech – Biotech bank balances were again in focus Monday morning, with Tango Therapeutics cutting preclinical work to stretch its cash runway and Avalo Therapeutics outlining options for preserving its money. Tango extended...
by admin | May 26, 2025 | News & Opinions
By Jon LaPook – CBS NEWS – Philadelphia — Soon after KJ Muldoon was born in the summer of 2024, he was diagnosed with a rare genetic disorder that is fatal for about half the infants who are born with it. Until now, the only effective long-term treatment...
